91036-4 |
Benzodiazepines |
PrThr |
Tiss |
Pt |
Ord |
Screen |
|
ACTIVE |
Benzodiazepines [Presence] in Tissue by Screen method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
91036-4 |
|
Screen |
|
|
Both |
|
|
|
0 |
Benzodiaz Tiss Ql Scn |
|
|
|
|
|
Benz; Benzodiaz; Benzodiazepine; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Tissue; Tissue, unspecified |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91037-2 |
Methamphetamine+Methylenedioxymethamphetamine |
PrThr |
Urine |
Pt |
Ord |
Screen |
|
ACTIVE |
Methamphetamine+Methylenedioxymethamphetamine [Presence] in Urine by Screen method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
91037-2 |
|
Screen |
|
|
Both |
|
|
|
0 |
Methamphet+MDMA Ur Ql Scn |
|
|
|
|
|
Addiction; Desoxyn; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecstasy; Illicit; MDMA; Methamphet; Methamphet+MDMA; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91038-0 |
Cocaine+Benzoylecgonine |
PrThr |
Body fld |
Pt |
Ord |
Screen |
|
ACTIVE |
Cocaine+Benzoylecgonine [Presence] in Body fluid by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
91038-0 |
|
Screen |
|
|
Both |
|
|
|
0 |
Cocaine+BZE Fld Ql Scn |
|
|
|
|
|
Addiction; B/F; BEC; BEG; Benz; Benzoylec; Benzoylmethylecgonine; BF; bod; Bodies; Body fluid; Body fluid, unsp; BZE; Cocaine degradation production; Cocaine metabolite; Cocaine+BZE; Coke; Crack; Crack metabolite; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecgonine methyl ester benzoate; Fl; Fld; FLU; Fluid; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Snow |
2.67 |
2.65 |
|
|
|
|
|
|
|
|
|
|
Release 2.67: EXAMPLE_UCUM_UNITS: Removed the Example UCUM units since the results for this concept are Ordinal. |
0 |
91039-8 |
Methadone+Metabolite |
PrThr |
Body fld |
Pt |
Ord |
Screen |
|
ACTIVE |
Methadone+Metabolite [Presence] in Body fluid by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
91039-8 |
|
Screen |
|
|
Both |
|
|
|
0 |
Methadone+metab Fld Ql Scn |
|
|
|
|
|
Addiction; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; Illicit; Metab; Metabolites; Metb; METD; Methadose; MTD; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn |
2.67 |
2.65 |
|
|
|
|
|
|
|
|
|
|
Release 2.67: EXAMPLE_UCUM_UNITS: Removed the Example UCUM units since the results for this concept are Ordinal. |
0 |
9104-1 |
Fluid intake.total |
VRat |
^Patient |
1H |
Qn |
|
|
ACTIVE |
Fluid intake total 1 hour |
|
MIN |
DefinitionDescription |
|
|
mL/h |
|
|
|
|
|
|
IO_IN.TIMED.MOLEC |
|
9104-1 |
|
|
|
|
|
|
|
|
0 |
Fluid intake total 1h |
|
|
|
|
|
1 hour; 1.0Hr; 1HR; 60 min; 60 minutes; 60M; 60min; Fld; Flow; Fluid intake total; IO_INTAKE; IO_INTAKE.TIMED.MOLEC; QNT; Quan; Quant; Quantitative; Tot; Totl; Volume rate; vRate |
2.48 |
1.0i |
|
|
|
|
|
|
|
mL/h |
|
|
|
0 |
91040-6 |
Phencyclidine |
PrThr |
Body fld |
Pt |
Ord |
Screen |
|
ACTIVE |
Phencyclidine [Presence] in Body fluid by Screen method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
91040-6 |
|
Screen |
|
|
Both |
|
|
|
0 |
PCP Fld Ql Scn |
|
|
|
|
|
Addiction; Angel dust; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; Illicit; Ordinal; PCP; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Sernylan |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91041-4 |
Cannabinoids |
PrThr |
Body fld |
Pt |
Ord |
Screen |
|
ACTIVE |
Cannabinoids [Presence] in Body fluid by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
91041-4 |
|
Screen |
|
|
Both |
|
|
|
0 |
Cannabinoids Fld Ql Scn |
|
|
|
|
|
Addiction; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cannabinoid; Delta-9-tetrahydrocannabinol; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; Illicit; Marijuana; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; THC |
2.67 |
2.65 |
|
|
|
|
|
|
|
|
|
|
Release 2.67: EXAMPLE_UCUM_UNITS: Removed the Example UCUM units since the results for this concept are Ordinal. |
0 |
91042-2 |
Methamphetamine+Methylenedioxymethamphetamine |
PrThr |
Body fld |
Pt |
Ord |
Screen |
|
ACTIVE |
Methamphetamine+Methylenedioxymethamphetamine [Presence] in Body fluid by Screen method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
91042-2 |
|
Screen |
|
|
Both |
|
|
|
0 |
Methamphet+MDMA Fld Ql Scn |
|
|
|
|
|
Addiction; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Desoxyn; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecstasy; Fl; Fld; FLU; Fluid; Illicit; MDMA; Methamphet; Methamphet+MDMA; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91043-0 |
Opiates |
PrThr |
Body fld |
Pt |
Ord |
Screen |
|
ACTIVE |
Opiates [Presence] in Body fluid by Screen method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
91043-0 |
|
Screen |
|
|
Both |
|
|
|
0 |
Opiates Fld Ql Scn |
|
|
|
|
|
Addiction; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; Heroin; Illicit; OP; Opi; Opiate; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91044-8 |
oxyCODONE+Oxymorphone |
PrThr |
Body fld |
Pt |
Ord |
Screen |
|
ACTIVE |
oxyCODONE+oxyMORphone [Presence] in Body fluid by Screen method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
91044-8 |
|
Screen |
|
|
Both |
|
|
|
0 |
oxyCODONE+oxyMORphone Fld Ql Scn |
|
|
|
|
|
14-Hydroxydihydromorphinone; Addiction; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; Illicit; Lortab; Numorphan; Numorphone; Opana; Ordinal; OxyContin; Percocet; Percodan; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Vicodin |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91045-5 |
Methamphetamine+Methylenedioxymethamphetamine |
PrThr |
Hair |
Pt |
Ord |
Screen |
|
ACTIVE |
Methamphetamine+Methylenedioxymethamphetamine [Presence] in Hair by Screen method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
91045-5 |
|
Screen |
|
|
Both |
|
|
|
0 |
Methamphet+MDMA Hair Ql Scn |
|
|
|
|
|
Addiction; Desoxyn; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecstasy; Har; Illicit; MDMA; Methamphet; Methamphet+MDMA; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91046-3 |
Methadone+Metabolite |
PrThr |
Hair |
Pt |
Ord |
Screen |
|
ACTIVE |
Methadone+Metabolite [Presence] in Hair by Screen method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
91046-3 |
|
Screen |
|
|
Both |
|
|
|
0 |
Methadone+metab Hair Ql Scn |
|
|
|
|
|
Addiction; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Har; Illicit; Metab; Metabolites; Metb; METD; Methadose; MTD; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91047-1 |
Barbiturates |
PrThr |
Hair |
Pt |
Ord |
Screen |
|
ACTIVE |
Barbiturates [Presence] in Hair by Screen method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
91047-1 |
|
Screen |
|
|
Both |
|
|
|
0 |
Barbiturates Hair Ql Scn |
|
|
|
|
|
Addiction; Barb; Barbiturate; Barbs; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Har; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91048-9 |
Cannabinoids |
PrThr |
Tiss |
Pt |
Ord |
Screen |
|
ACTIVE |
Cannabinoids [Presence] in Tissue by Screen method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
91048-9 |
|
Screen |
|
|
Both |
|
|
|
0 |
Cannabinoids Tiss Ql Scn |
|
|
|
|
|
Addiction; Cannabinoid; Delta-9-tetrahydrocannabinol; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Marijuana; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; THC; Tissue; Tissue, unspecified |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91049-7 |
Cocaine+Benzoylecgonine |
PrThr |
Tiss |
Pt |
Ord |
Screen |
|
ACTIVE |
Cocaine+Benzoylecgonine [Presence] in Tissue by Screen method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
91049-7 |
|
Screen |
|
|
Both |
|
|
|
0 |
Cocaine+BZE Tiss Ql Scn |
|
|
|
|
|
Addiction; BEC; BEG; Benz; Benzoylec; Benzoylmethylecgonine; BZE; Cocaine degradation production; Cocaine metabolite; Cocaine+BZE; Coke; Crack; Crack metabolite; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecgonine methyl ester benzoate; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Snow; Tissue; Tissue, unspecified |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
9105-8 |
Fluid intake.total |
VRat |
^Patient |
8H |
Qn |
|
|
ACTIVE |
Fluid intake total 8 hour |
|
MIN |
DefinitionDescription |
|
|
mL/8 H |
|
|
|
|
|
|
IO_IN.TIMED.MOLEC |
|
9105-8 |
|
|
|
|
|
|
|
|
0 |
Fluid intake total 8h |
|
|
|
|
|
1/3 day; 8 hours; 8HR; Fld; Flow; Fluid intake total; IO_INTAKE; IO_INTAKE.TIMED.MOLEC; QNT; Quan; Quant; Quantitative; Tot; Totl; Volume rate; vRate |
2.48 |
1.0i |
|
|
|
|
|
|
|
mL/(8.h) |
|
|
|
0 |
91050-5 |
Methadone+Metabolite |
PrThr |
Tiss |
Pt |
Ord |
Screen |
|
ACTIVE |
Methadone+Metabolite [Presence] in Tissue by Screen method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
91050-5 |
|
Screen |
|
|
Both |
|
|
|
0 |
Methadone+metab Tiss Ql Scn |
|
|
|
|
|
Addiction; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Metab; Metabolites; Metb; METD; Methadose; MTD; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Tissue; Tissue, unspecified |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91051-3 |
Methamphetamine+Methylenedioxymethamphetamine |
PrThr |
Tiss |
Pt |
Ord |
Screen |
|
ACTIVE |
Methamphetamine+Methylenedioxymethamphetamine [Presence] in Tissue by Screen method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
91051-3 |
|
Screen |
|
|
Both |
|
|
|
0 |
Methamphet+MDMA Tiss Ql Scn |
|
|
|
|
|
Addiction; Desoxyn; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecstasy; Illicit; MDMA; Methamphet; Methamphet+MDMA; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Tissue; Tissue, unspecified |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91052-1 |
Opiates |
PrThr |
Tiss |
Pt |
Ord |
Screen |
|
ACTIVE |
Opiates [Presence] in Tissue by Screen method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
91052-1 |
|
Screen |
|
|
Both |
|
|
|
0 |
Opiates Tiss Ql Scn |
|
|
|
|
|
Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Heroin; Illicit; OP; Opi; Opiate; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Tissue; Tissue, unspecified |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91053-9 |
oxyCODONE+Oxymorphone |
PrThr |
Tiss |
Pt |
Ord |
Screen |
|
ACTIVE |
oxyCODONE+oxyMORphone [Presence] in Tissue by Screen method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
91053-9 |
|
Screen |
|
|
Both |
|
|
|
0 |
oxyCODONE+oxyMORphone Tiss Ql Scn |
|
|
|
|
|
14-Hydroxydihydromorphinone; Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Lortab; Numorphan; Numorphone; Opana; Ordinal; OxyContin; Percocet; Percodan; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Tissue; Tissue, unspecified; Vicodin |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91054-7 |
Drugs of abuse panel |
- |
Body fld |
Pt |
- |
|
|
ACTIVE |
Drugs of abuse panel - Body fluid |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.DRUG/TOX |
|
91054-7 |
|
|
|
|
Order |
|
|
|
0 |
Drugs of abuse Pnl Fld |
|
|
|
|
|
B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DAU; Drug; DRUG/TOXICOLOGY; Drugs; Drugs of abuse Pnl; Fl; Fld; FLU; Fluid; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random |
2.65 |
2.65 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
91055-4 |
Drugs of abuse panel |
- |
Tiss |
Pt |
- |
|
|
ACTIVE |
Drugs of abuse panel - Tissue |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.DRUG/TOX |
|
91055-4 |
|
|
|
|
Order |
|
|
|
0 |
Drugs of abuse Pnl Tiss |
|
|
|
|
|
DAU; Drug; DRUG/TOXICOLOGY; Drugs; Drugs of abuse Pnl; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; Tissue; Tissue, unspecified |
2.65 |
2.65 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
91056-2 |
Drugs of abuse panel |
- |
Hair |
Pt |
- |
|
|
ACTIVE |
Drugs of abuse panel - Hair |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.DRUG/TOX |
|
91056-2 |
|
|
|
|
Order |
|
|
|
0 |
Drugs of abuse Pnl Hair |
|
|
|
|
|
DAU; Drug; DRUG/TOXICOLOGY; Drugs; Drugs of abuse Pnl; Har; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random |
2.65 |
2.65 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
91057-0 |
Tropheryma whipplei DNA |
PrThr |
Stool |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Tropheryma whipplei DNA [Presence] in Stool by NAA with probe detection |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91057-0 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
T whipplei DNA Stl Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; T whippelii; T whippelli; T whipplei; TMA; Transcription mediated amplification; Tropheryma whippelli; Whipple's disease |
2.7 |
2.65 |
|
|
|
|
|
|
|
|
|
|
Release 2.70: COMPONENT: Corrected spelling of species name from "whippelii"; |
0 |
91058-8 |
Kingella kingae DNA |
PrThr |
Synv fld |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Kingella kingae DNA [Presence] in Synovial fluid by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91058-8 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
K kingae DNA Snv Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Joint aspirate; Joint fld; Joint flu; Joint fluid; K kingae; K kingella; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Moraxella kingae; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Rheum; Rheumatology; Screen; SDA; SF; SNV; Strand Displacement Amplification; Syn; Syn fl; Synov; Synovial fluid; TMA; Transcription mediated amplification |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |